Mr. Speaker, since 2018, our government has been working with British Columbia on the litigation against big pharma and those that enabled it, including a specific class action lawsuit against McKinsey. If it is certified, we intend to officially become part of that lawsuit. Canada has also addressed big pharma's predatory practices by further restricting the marketing of opioids.
In the House of Commons on June 19th, 2023. See this statement in context.